TOKYO--(BUSINESS WIRE)--R-Tech Ueno (JASDAQ:4573) has announced The International Court of Arbitration, International Chamber of Commerce (“ICC”), has issued its arbitral award in the arbitration filed by R-Tech Ueno, Ltd., together with Sucampo Pharmaceuticals, Inc. (“Sucampo”) and Sucampo AG, against Takeda Pharmaceutical Company Ltd. (“Takeda”). The arbitral award stipulated that the claims of R-Tech Ueno were not accepted and the Supply Agreement among R-Tech Ueno, Takeda and Sucampo executed in 2004 regarding the exclusive supply of AMITIZA® capsules shall continue to be in effect. No damages were rendered.
